Grow

Search This Blog

Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?

December 16, 2022

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.

By Andrew Jacobs | NYTimes | NYT > Business | Disclosure

NYT NYT > Business NYTimes Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Comments

Ticketmaster Confirms Data Breach. Here’s What to Know.

The hacking group ShinyHunters has claimed responsibility for stealing the user information of more than 500 million Ticketmaster customers. By Sopan Deb | NYTimes | NYT > Business | Disclosure

The Napoleon of Your Living Room

Gary Friedman, who runs RH (formerly Restoration Hardware), is out to conquer the world, one luxurious sofa at a time. Next stop, Waterloo? By David Segal | NYTimes | NYT > Business | Disclosure

Kia Recalls Telluride SUV Over Fire Risk; Urging Owners to Park Outside

About 460,000 vehicles could be affected by the recall, which stems from a problem with the vehicle’s front power seat motor. By Aimee Ortiz | NYTimes | NYT > Business | Disclosure

F.A.A. Investigating How Counterfeit Titanium Got Into Boeing and Airbus Jets

The material, which was purchased from a little-known Chinese company, was sold with falsified documents and used in parts that went into jets from both manufacturers. By Mark Walker | NYTimes | NYT > Business | Disclosure

The Business of Being Lorne Michaels

For 50 years, Michaels has managed both the weekly circus of producing “Saturday Night Live” and the broader task of keeping it relevant. How does he do it? By Lauren Hirsch | NYTimes | NYT > Business | Disclosure

Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?

Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.

Comments

Post a Comment